(-)-demecolcine decreases expression ISO RGD:1605124 6480464 Demecolcine results in decreased expression of NASP mRNA CTD PMID:23649840 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of NASP mRNA CTD PMID:17557909 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1552828 6480464 [2 more ... CTD PMID:25510870 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1605124 6480464 2 more ... CTD PMID:19095052 , PMID:31675489 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1552828 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of NASP mRNA CTD PMID:21215274 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of NASP mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1552828 6480464 Tetrachlorodibenzodioxin results in increased expression of NASP mRNA CTD PMID:15034205 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1605124 6480464 Tetrachlorodibenzodioxin affects the expression of NASP mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1552828 6480464 Tetrachlorodibenzodioxin affects the expression of NASP mRNA CTD PMID:21570461 2,4,6-tribromophenol decreases expression ISO RGD:1605124 6480464 2 more ... CTD PMID:31675489 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression ISO RGD:1605124 6480464 2 more ... CTD PMID:26705709 2-amino-14,16-dimethyloctadecan-3-ol decreases expression ISO RGD:1605124 6480464 2-amino-14, 16-dimethyloctadecan-3-ol results in decreased expression of NASP protein CTD PMID:32044396 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:1605124 6480464 tetrabromobisphenol A results in decreased expression of NASP protein CTD PMID:31675489 3,7-dihydropurine-6-thione decreases expression EXP 6480464 Mercaptopurine results in decreased expression of NASP mRNA CTD PMID:23358152 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of NASP protein CTD PMID:34915118 3-methylcholanthrene increases expression ISO RGD:1552828 6480464 Methylcholanthrene results in increased expression of NASP mRNA CTD PMID:20713471 4-hydroxyphenyl retinamide increases expression ISO RGD:1552828 6480464 Fenretinide results in increased expression of NASP mRNA CTD PMID:28973697 5-fluorouracil multiple interactions ISO RGD:1605124 6480464 TP53 protein affects the reaction [Fluorouracil results in decreased expression of NASP mRNA] CTD PMID:15016801 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of NASP mRNA CTD PMID:24780913 acrolein multiple interactions ISO RGD:1605124 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NASP mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NASP mRNA CTD PMID:32699268 all-trans-retinoic acid decreases expression ISO RGD:1605124 6480464 Tretinoin results in decreased expression of NASP mRNA CTD PMID:21934132 , PMID:33167477 alpha-pinene multiple interactions ISO RGD:1605124 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NASP mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NASP mRNA CTD PMID:32699268 antirheumatic drug decreases expression ISO RGD:1605124 6480464 Antirheumatic Agents results in decreased expression of NASP mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:1605124 6480464 aristolochic acid I results in decreased expression of NASP mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO RGD:1552828 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of NASP mRNA CTD PMID:23650126 arsenous acid increases response to substance ISO RGD:1605124 6480464 NASP protein results in increased susceptibility to Arsenic Trioxide CTD PMID:20707922 azathioprine decreases expression ISO RGD:1605124 6480464 Azathioprine results in decreased expression of NASP mRNA CTD PMID:22623647 Benoxacor increases expression ISO RGD:1552828 6480464 benoxacor results in increased expression of NASP mRNA CTD PMID:34850242 benzo[a]pyrene decreases expression ISO RGD:1605124 6480464 Benzo(a)pyrene results in decreased expression of NASP mRNA CTD PMID:21632981 benzo[a]pyrene increases expression ISO RGD:1552828 6480464 Benzo(a)pyrene results in increased expression of NASP mRNA CTD PMID:15034205 more ... benzo[a]pyrene decreases expression ISO RGD:1552828 6480464 Benzo(a)pyrene results in decreased expression of NASP mRNA CTD PMID:15034205 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1605124 6480464 7 more ... CTD PMID:19150397 , PMID:20382639 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1605124 6480464 Diethylhexyl Phthalate results in increased expression of NASP protein CTD PMID:31163220 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of NASP mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1552828 6480464 bisphenol A results in decreased expression of NASP mRNA CTD PMID:33221593 bisphenol A affects expression ISO RGD:1605124 6480464 bisphenol A affects the expression of NASP mRNA CTD PMID:30903817 bisphenol A decreases expression ISO RGD:1605124 6480464 bisphenol A results in decreased expression of NASP mRNA, bisphenol A results in decreased expression of NASP protein CTD PMID:29275510 , PMID:31675489 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of NASP mRNA CTD PMID:30816183 , PMID:34947998 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of NASP gene CTD PMID:28505145 caffeine affects phosphorylation ISO RGD:1605124 6480464 Caffeine affects the phosphorylation of NASP protein CTD PMID:35688186 calcitriol decreases expression ISO RGD:1605124 6480464 Calcitriol results in decreased expression of NASP mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1605124 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of NASP mRNA CTD PMID:21592394 carbamazepine affects expression ISO RGD:1605124 6480464 Carbamazepine affects the expression of NASP mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:1552828 6480464 Nanotubes more ... CTD PMID:25554681 chromium(6+) affects expression ISO RGD:1552828 6480464 chromium hexavalent ion affects the expression of NASP mRNA CTD PMID:28472532 clothianidin decreases expression ISO RGD:1605124 6480464 clothianidin results in decreased expression of NASP mRNA CTD PMID:31626844 cobalt dichloride decreases expression ISO RGD:1605124 6480464 cobaltous chloride results in decreased expression of NASP mRNA CTD PMID:19376846 copper atom multiple interactions ISO RGD:1605124 6480464 [NSC 689534 binds to Copper] which results in decreased expression of NASP mRNA CTD PMID:20971185 copper atom increases expression EXP 6480464 Copper results in increased expression of NASP mRNA CTD PMID:30556269 copper(0) multiple interactions ISO RGD:1605124 6480464 [NSC 689534 binds to Copper] which results in decreased expression of NASP mRNA CTD PMID:20971185 copper(0) increases expression EXP 6480464 Copper results in increased expression of NASP mRNA CTD PMID:30556269 coumarin decreases phosphorylation ISO RGD:1605124 6480464 coumarin results in decreased phosphorylation of NASP protein CTD PMID:35688186 coumestrol increases expression ISO RGD:1605124 6480464 Coumestrol results in increased expression of NASP mRNA CTD PMID:19167446 coumestrol multiple interactions ISO RGD:1605124 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 cyclophosphamide increases expression EXP 6480464 Cyclophosphamide results in increased expression of NASP mRNA CTD PMID:16141653 cyclosporin A decreases expression ISO RGD:1605124 6480464 Cyclosporine results in decreased expression of NASP mRNA CTD PMID:21632981 , PMID:25562108 decabromodiphenyl ether decreases expression ISO RGD:1605124 6480464 decabromobiphenyl ether results in decreased expression of NASP protein CTD PMID:31675489 diarsenic trioxide increases response to substance ISO RGD:1605124 6480464 NASP protein results in increased susceptibility to Arsenic Trioxide CTD PMID:20707922 dibutyl phthalate decreases expression ISO RGD:1552828 6480464 Dibutyl Phthalate results in decreased expression of NASP mRNA CTD PMID:17361019 , PMID:21266533 dorsomorphin multiple interactions ISO RGD:1605124 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NASP mRNA CTD PMID:27188386 doxorubicin affects expression ISO RGD:1605124 6480464 Doxorubicin affects the expression of NASP protein CTD PMID:29385562 elemental selenium increases expression ISO RGD:1605124 6480464 Selenium results in increased expression of NASP mRNA CTD PMID:19244175 Enterolactone multiple interactions ISO RGD:1605124 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NASP mRNA CTD PMID:19167446 enzyme inhibitor multiple interactions ISO RGD:1605124 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NASP protein CTD PMID:23301498 ethanol decreases expression ISO RGD:1605124 6480464 Ethanol results in decreased expression of NASP mRNA CTD PMID:28986285 flutamide increases expression EXP 6480464 Flutamide results in increased expression of NASP mRNA CTD PMID:24136188 folic acid increases expression ISO RGD:1605124 6480464 Folic Acid results in increased expression of NASP mRNA CTD PMID:21867686 geldanamycin increases expression ISO RGD:1605124 6480464 geldanamycin results in increased expression of NASP mRNA CTD PMID:26705709 genistein decreases expression ISO RGD:1605124 6480464 Genistein results in decreased expression of NASP protein CTD PMID:20884965 genistein multiple interactions ISO RGD:1605124 6480464 ESR1 promotes the reaction [Genistein results in decreased expression of NASP protein] CTD PMID:20884965 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of NASP mRNA CTD PMID:33387578 geraniol decreases expression ISO RGD:1605124 6480464 geraniol results in decreased expression of NASP mRNA CTD PMID:27683099 hydrogen peroxide increases phosphorylation ISO RGD:1552828 6480464 Hydrogen Peroxide results in increased phosphorylation of NASP protein CTD PMID:31494107 hydrogen peroxide multiple interactions ISO RGD:1552828 6480464 N-(oxo-5 more ... CTD PMID:31494107 isobutanol multiple interactions ISO RGD:1605124 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of NASP mRNA CTD PMID:29432896 ivermectin decreases expression ISO RGD:1605124 6480464 Ivermectin results in decreased expression of NASP protein CTD PMID:32959892 mercaptopurine decreases expression EXP 6480464 Mercaptopurine results in decreased expression of NASP mRNA CTD PMID:23358152 methylmercury chloride increases expression ISO RGD:1605124 6480464 methylmercuric chloride results in increased expression of NASP mRNA CTD PMID:23179753 , PMID:27188386 methylmercury chloride decreases expression ISO RGD:1605124 6480464 methylmercuric chloride results in decreased expression of NASP mRNA CTD PMID:28001369 miconazole decreases expression ISO RGD:1552828 6480464 Miconazole results in decreased expression of NASP mRNA CTD PMID:27462272 N-methyl-4-phenylpyridinium increases expression ISO RGD:1552828 6480464 1-Methyl-4-phenylpyridinium results in increased expression of NASP protein CTD PMID:26558463 N-nitrosodiethylamine increases expression ISO RGD:1552828 6480464 Diethylnitrosamine results in increased expression of NASP mRNA CTD PMID:17854601 N-nitrosodiethylamine multiple interactions ISO RGD:1552828 6480464 RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of NASP mRNA] CTD PMID:17854601 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of NASP mRNA CTD PMID:25729387 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of NASP mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1605124 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NASP mRNA more ... CTD PMID:32699268 ozone multiple interactions ISO RGD:1552828 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of NASP mRNA, [Air Pollutants results in increased abundance of Ozone] which results in increased expression of NASP mRNA CTD PMID:34911549 paracetamol affects expression ISO RGD:1552828 6480464 Acetaminophen affects the expression of NASP mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of NASP mRNA CTD PMID:33387578 PCB138 multiple interactions ISO RGD:1552828 6480464 [2 more ... CTD PMID:25510870 phenobarbital affects expression ISO RGD:1605124 6480464 Phenobarbital affects the expression of NASP mRNA CTD PMID:19159669 phenobarbital affects expression ISO RGD:1552828 6480464 Phenobarbital affects the expression of NASP mRNA CTD PMID:23091169 phenylmercury acetate decreases expression ISO RGD:1605124 6480464 Phenylmercuric Acetate results in decreased expression of NASP mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1605124 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NASP mRNA CTD PMID:27188386 piroxicam decreases expression ISO RGD:1605124 6480464 Piroxicam results in decreased expression of NASP mRNA CTD PMID:21858171 purine-6-thiol decreases expression EXP 6480464 Mercaptopurine results in decreased expression of NASP mRNA CTD PMID:23358152 resveratrol decreases expression ISO RGD:1605124 6480464 resveratrol results in decreased expression of NASP mRNA CTD PMID:19371625 resveratrol multiple interactions ISO RGD:1605124 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of NASP mRNA CTD PMID:19167446 rotenone increases expression EXP 6480464 Rotenone results in increased expression of NASP mRNA CTD PMID:19013527 SB 431542 multiple interactions ISO RGD:1605124 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NASP mRNA CTD PMID:27188386 selenium atom increases expression ISO RGD:1605124 6480464 Selenium results in increased expression of NASP mRNA CTD PMID:19244175 sodium arsenite increases stability ISO RGD:1605124 6480464 sodium arsenite results in increased stability of NASP mRNA CTD PMID:25493608 sodium arsenite increases expression ISO RGD:1605124 6480464 sodium arsenite results in increased expression of NASP mRNA CTD PMID:34032870 sunitinib decreases expression ISO RGD:1605124 6480464 Sunitinib results in decreased expression of NASP mRNA CTD PMID:31533062 testosterone multiple interactions ISO RGD:1605124 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of NASP mRNA CTD PMID:21592394 testosterone decreases expression ISO RGD:1605124 6480464 Testosterone results in decreased expression of NASP mRNA CTD PMID:21592394 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of NASP mRNA CTD PMID:31150632 thapsigargin decreases expression EXP 6480464 Thapsigargin results in decreased expression of NASP protein CTD PMID:35544339 thimerosal decreases expression ISO RGD:1605124 6480464 Thimerosal results in decreased expression of NASP mRNA CTD PMID:27188386 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of NASP mRNA CTD PMID:34492290 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of NASP mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of NASP mRNA CTD PMID:25729387 triadimefon increases expression ISO RGD:1605124 6480464 triadimefon results in increased expression of NASP mRNA CTD PMID:26705709 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of NASP mRNA CTD PMID:33387578 trimellitic anhydride increases expression ISO RGD:1552828 6480464 trimellitic anhydride results in increased expression of NASP mRNA CTD PMID:19042947 troglitazone decreases expression ISO RGD:1605124 6480464 troglitazone results in decreased expression of NASP mRNA CTD PMID:19140230 trovafloxacin decreases expression ISO RGD:1552828 6480464 trovafloxacin results in decreased expression of NASP mRNA CTD PMID:35537566 valproic acid increases methylation ISO RGD:1605124 6480464 Valproic Acid results in increased methylation of NASP gene CTD PMID:29154799 valproic acid decreases expression ISO RGD:1605124 6480464 Valproic Acid results in decreased expression of NASP mRNA CTD PMID:28001369 valproic acid increases expression ISO RGD:1605124 6480464 Valproic Acid results in increased expression of NASP mRNA CTD PMID:28001369 vancomycin decreases expression ISO RGD:1552828 6480464 Vancomycin results in decreased expression of NASP mRNA CTD PMID:18930951 venlafaxine hydrochloride increases expression ISO RGD:1605124 6480464 Venlafaxine Hydrochloride results in increased expression of NASP mRNA CTD PMID:16341940 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of NASP mRNA CTD PMID:23034163 vincristine decreases expression ISO RGD:1605124 6480464 Vincristine results in decreased expression of NASP mRNA CTD PMID:23649840 vorinostat decreases expression ISO RGD:1605124 6480464 vorinostat results in decreased expression of NASP mRNA CTD PMID:27188386 zearalenone decreases expression EXP 6480464 Zearalenone results in decreased expression of NASP mRNA CTD PMID:17557909